Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
clinical hold
Biotech
FDA allows BioNTech-MediLink ADC trial to resume at lower doses
BioNTech confirmed that it would focus solely on doses no higher than 3 mg/kg.
James Waldron
Aug 19, 2024 8:45am
Stoke's Dravet syndrome med released of partial clinical hold
Aug 7, 2024 8:54am
FDA puts vTv's diabetes drug on hold over chromatographic signal
Jul 29, 2024 4:47am
FDA places hold on Zentalis’ WEE1 drug after two sepsis deaths
Jun 18, 2024 8:21am
FDA halts BioNTech ADC trial over 'significant risk of illness'
Jun 17, 2024 9:17am
Diabetes biotech stock tanks as FDA imposes full clinical hold
Jun 7, 2024 8:13am
